RavenQuest BioMed Inc. (RVVQF)

USD 0.0

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2018 2017 2016 2015 2014 2013
Revenue 1.25 Million 112.35 Thousand - - - -
Cost of Revenue 455.44 Thousand 97.69 Thousand - - - -
Gross Profit 801.29 Thousand 14.65 Thousand - - - -
Operating Expenses 17.97 Million 656.26 Thousand 81.45 Thousand 76.09 Thousand 62.33 Thousand 105.17 Thousand
Selling, General and Administrative Expenses 11.18 Million 634.09 Thousand 80.11 Thousand 79.39 Thousand 84.03 Thousand 100.62 Thousand
Research and Development Expenses 80 Thousand - - - - -
Other Expenses -10.19 Thousand - - 6600.00 1709.00 -
Cost and Expenses 18.43 Million 753.96 Thousand 81.45 Thousand 76.09 Thousand 62.33 Thousand 105.17 Thousand
Operating Income -17.17 Million -641.61 Thousand -81.45 Thousand -82.69 Thousand -87.33 Thousand -105.17 Thousand
Interest Expense 1.9 Million 147.05 Thousand - - - -
Income Tax Expense -578 Thousand 147 Thousand -22.81 Thousand -6662.00 -25.06 Thousand -60.00
Earnings before Tax -31.04 Million -3.3 Million -81.45 Thousand -76.02 Thousand -60.56 Thousand -502.22 Thousand
Net Income -30.46 Million -3.3 Million -81.45 Thousand -76.02 Thousand -60.56 Thousand -502.22 Thousand
Earnings Per Share Basic -0.33 -0.10 -0.00 -0.00 -0.00 -0.02
Earnings Per Share Diluted -0.33 -0.10 -0.00 -0.00 -0.00 -0.02
Weighted Average Shares Outstanding 91.03 Million 32.47 Million 29 Million 29 Million 29 Million 29 Million
Weighted Average Shares Outstanding (Diluted) 91.03 Million 32.47 Million 29 Million 29 Million 29 Million 29 Million
Gross Margin 0.64 0.13 - - - -
EBIT Margin -12.17 -5.71 - - - -
Profit Margin -24.24 -29.38 - - - -
EBITDA -15.29 Million -641.32 Thousand -81.45 Thousand -76.08 Thousand -62.33 Thousand 291.92 Thousand
Earnings Before Tax Margin -13.67 -5.71 - - - -

Income Statement Charts